On Tuesday, Glaukos Corporation (NYSE: GKOS) opened higher 0.02% from the last session, before settling in for the closing price of $93.81. Price fluctuations for GKOS have ranged from $77.91 to $163.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.99% over the last five years. Company’s average yearly earnings per share was noted 47.32% at the time writing. With a float of $54.98 million, this company’s outstanding shares have now reached $56.44 million.
The firm has a total of 995 workers. Let’s measure their productivity. In terms of profitability, gross margin is 75.48%, operating margin of -28.2%, and the pretax margin is -37.97%.
Glaukos Corporation (GKOS) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Glaukos Corporation is 3.69%, while institutional ownership is 100.24%. The most recent insider transaction that took place on Mar 25 ’25, was worth 162,399. In this transaction SVP & CHIEF FINANCIAL OFFICER of this company sold 1,520 shares at a rate of $106.84, taking the stock ownership to the 53,431 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Officer proposed sale 1,520 for $106.84, making the entire transaction worth $162,402.
Glaukos Corporation (GKOS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 47.32% per share during the next fiscal year.
Glaukos Corporation (NYSE: GKOS) Trading Performance Indicators
Check out the current performance indicators for Glaukos Corporation (GKOS). In the past quarter, the stock posted a quick ratio of 5.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.81, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Glaukos Corporation (GKOS)
Analysing the last 5-days average volume posted by the [Glaukos Corporation, GKOS], we can find that recorded value of 0.8 million was lower than the volume posted last year of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 67.83%. Additionally, its Average True Range was 5.35.
During the past 100 days, Glaukos Corporation’s (GKOS) raw stochastic average was set at 18.55%, which indicates a significant decrease from 72.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.46% in the past 14 days, which was higher than the 64.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $103.88, while its 200-day Moving Average is $128.22. Now, the first resistance to watch is $94.76. This is followed by the second major resistance level at $95.69. The third major resistance level sits at $96.66. If the price goes on to break the first support level at $92.86, it is likely to go to the next support level at $91.89. Should the price break the second support level, the third support level stands at $90.96.
Glaukos Corporation (NYSE: GKOS) Key Stats
There are currently 57,086K shares outstanding in the company with a market cap of 5.36 billion. Presently, the company’s annual sales total 383,480 K according to its annual income of -146,370 K. Last quarter, the company’s sales amounted to 105,500 K and its income totaled -33,580 K.
